Shuttle Pharmaceuticals Holdings, Inc. (SHPH)

USD 0.28

(1.32%)

Gross Profit Summary of Shuttle Pharmaceuticals Holdings, Inc.

  • Shuttle Pharmaceuticals Holdings, Inc.'s latest annual gross profit in 2023 was -6811.00 USD , up 89.81% from previous year.
  • Shuttle Pharmaceuticals Holdings, Inc.'s latest quarterly gross profit in 2024 Q2 was -962.00 USD , up 49.69% from previous quarter.
  • Shuttle Pharmaceuticals Holdings, Inc. reported a annual gross profit of -66.83 Thousand USD in annual gross profit 2022, down -9.86% from previous year.
  • Shuttle Pharmaceuticals Holdings, Inc. reported a annual gross profit of -60.83 Thousand USD in annual gross profit 2021, down -10.71% from previous year.
  • Shuttle Pharmaceuticals Holdings, Inc. reported a quarterly gross profit of -962.00 USD for 2024 Q2, up 49.69% from previous quarter.
  • Shuttle Pharmaceuticals Holdings, Inc. reported a quarterly gross profit of -1482.00 USD for 2023 Q2, up 0.4% from previous quarter.

Annual Gross Profit Chart of Shuttle Pharmaceuticals Holdings, Inc. (2023 - 2017)

Historical Annual Gross Profit of Shuttle Pharmaceuticals Holdings, Inc. (2023 - 2017)

Year Gross Profit Gross Profit Growth
2023 -6811.00 USD 89.81%
2022 -66.83 Thousand USD -9.86%
2021 -60.83 Thousand USD -10.71%
2020 -54.95 Thousand USD 0.0%
2018 -18 Thousand USD 3.94%
2017 -18.73 Thousand USD 0.0%

Peer Gross Profit Comparison of Shuttle Pharmaceuticals Holdings, Inc.

Name Gross Profit Gross Profit Difference
ANI Pharmaceuticals, Inc. 305.3 Million USD 100.002%
Aquestive Therapeutics, Inc. 29.75 Million USD 100.023%
Collegium Pharmaceutical, Inc. 326.16 Million USD 100.002%
Cosmos Health Inc. 4.34 Million USD 100.157%
Cyclo Therapeutics, Inc. -2.41 Million USD 99.717%
Esperion Therapeutics, Inc. 73.06 Million USD 100.009%
Cronos Group Inc. 6.99 Million USD 100.097%
Incannex Healthcare Limited 12 Thousand USD 156.758%
Kala Pharmaceuticals, Inc. -303 Thousand USD 97.752%
Lifecore Biomedical, Inc. 41.85 Million USD 100.016%
Regencell Bioscience Holdings Limited -745.58 Thousand USD 99.086%
Sunshine Biopharma, Inc. 8.33 Million USD 100.082%
Sunshine Biopharma, Inc. 8.33 Million USD 100.082%
SCYNEXIS, Inc. 124.51 Million USD 100.005%
Safety Shot Inc -74.45 Thousand USD 90.852%
Theratechnologies Inc. 62.12 Million USD 100.011%
Alpha Teknova, Inc. 10.29 Million USD 100.066%
Universe Pharmaceuticals INC 10.07 Million USD 100.068%
Pacira BioSciences, Inc. 490.3 Million USD 100.001%
Sonoma Pharmaceuticals, Inc. 4.74 Million USD 100.144%
Dynavax Technologies Corporation 182.11 Million USD 100.004%
Ironwood Pharmaceuticals, Inc. 441.16 Million USD 100.002%
Radius Health, Inc. 307.71 Million USD 100.002%
China SXT Pharmaceuticals, Inc. 553.97 Thousand USD 101.229%
Alvotech -69.42 Million USD 99.99%
Intra-Cellular Therapies, Inc. 430.62 Million USD 100.002%
SIGA Technologies, Inc. 122.09 Million USD 100.006%
Shineco, Inc. 882.16 Thousand USD 100.772%
Silver Spike Investment Corp. 8.1 Million USD 100.084%
Journey Medical Corporation 52.52 Million USD 100.013%
Petros Pharmaceuticals, Inc. 4.19 Million USD 100.163%
Embecta Corp. 749.9 Million USD 100.001%
Harrow Health, Inc. 90.55 Million USD 100.008%
Procaps Group, S.A. 239.56 Million USD 100.003%
Biofrontera Inc. 16.62 Million USD 100.041%
DURECT Corporation 6.83 Million USD 100.1%
PainReform Ltd. -15 Thousand USD 54.593%
Supernus Pharmaceuticals, Inc. 523.74 Million USD 100.001%
OptiNose, Inc. 62.35 Million USD 100.011%
RedHill Biopharma Ltd. 3.05 Million USD 100.223%
Organogenesis Holdings Inc. 309.79 Million USD 100.002%
Cumberland Pharmaceuticals Inc. 33.48 Million USD 100.02%
ProPhase Labs, Inc. 16.23 Million USD 100.042%
Phibro Animal Health Corporation 312.48 Million USD 100.002%
Procaps Group S.A. 239.56 Million USD 100.003%
TherapeuticsMD, Inc. 1.3 Million USD 100.523%
Viatris Inc. 6.43 Billion USD 100.0%
Rockwell Medical, Inc. 8.7 Million USD 100.078%
Aytu BioPharma, Inc. 54.58 Million USD 100.012%
Tilray Brands, Inc. 223.35 Million USD 100.003%
PetIQ, Inc. 252.74 Million USD 100.003%
Talphera, Inc. -4.89 Million USD 99.861%
Neurocrine Biosciences, Inc. 1.84 Billion USD 100.0%
Alimera Sciences, Inc. 61.17 Million USD 100.011%
Assertio Holdings, Inc. 125.04 Million USD 100.005%
Avadel Pharmaceuticals plc 27.11 Million USD 100.025%
Hempacco Co., Inc. -1.21 Million USD 99.44%
Alvotech -69.42 Million USD 99.99%
Lantheus Holdings, Inc. 709.54 Million USD 100.001%
Kamada Ltd. 52.59 Million USD 100.013%
Currenc Group, Inc. 17.35 Million USD 100.039%
Indivior PLC 907 Million USD 100.001%
Evoke Pharma, Inc. 4.97 Million USD 100.137%
Flora Growth Corp. 17.73 Million USD 100.038%
Cyclo Therapeutics, Inc. -2.41 Million USD 99.717%
Evolus, Inc. 140.52 Million USD 100.005%
HUTCHMED (China) Limited 453.55 Million USD 100.002%
Amphastar Pharmaceuticals, Inc. 343.96 Million USD 100.002%
Akanda Corp. 111.44 Thousand USD 106.111%